mRNA |
ML311 |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
fingolimod |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
istradefylline |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.8 |
mRNA |
FQI-1 |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.8 |
mRNA |
BRD-K71781559 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.8 |
mRNA |
hyperforin |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.8 |
mRNA |
KX2-391 |
CTRPv2 |
pan-cancer |
AAC |
-0.0095 |
0.8 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |